These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5488337)

  • 1. Possible immune factors in spontaneous regression of bronchogenic carcinoma. Ten year survival in a patient treated with minimal (1,200 r) radiation alone.
    Bell JW
    Am J Surg; 1970 Dec; 120(6):804-6. PubMed ID: 5488337
    [No Abstract]   [Full Text] [Related]  

  • 2. Spontaneous regression of bronchogenic carcinoma.
    Baker RR
    Natl Cancer Inst Monogr; 1976 Nov; 44():31-3. PubMed ID: 193021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation therapy in the management of carcinoma of the lung.
    Perez CA
    Cancer; 1977 Feb; 39(2 Suppl):901-16. PubMed ID: 189898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous regression of bronchogenic carcinoma. Twelve-year survival.
    Emerson GL; Emerson MS; Sherwood CE; Terry R
    J Thorac Cardiovasc Surg; 1968 Feb; 55(2):225-30. PubMed ID: 5635979
    [No Abstract]   [Full Text] [Related]  

  • 5. Panel report. Radiotherapy for lung cancer.
    Rubin P
    Cancer Chemother Rep 3; 1973 Mar; 4(2):311-5. PubMed ID: 4729336
    [No Abstract]   [Full Text] [Related]  

  • 6. Radiotherapy plus 5-FU compared to radiotherapy alone for inoperable and unresectable bronchogenic carcinoma.
    Carr DT; Childs DS; Lee RE
    Cancer; 1972 Feb; 29(2):375-80. PubMed ID: 4622422
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytotoxic activity of lymphocytes to bronchogenic carcinoma cells in patients with lung cancer.
    Yasumoto K; Ohta M; Nomoto K
    Gan; 1976 Aug; 67(4):505-11. PubMed ID: 1030675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune reactivity in bronchogenic carcinoma and its relation to 5-year survival rate.
    Watanabe Y; Shimizu J; Hashizume Y; Tsunamura Y; Yamada T; Iwa T; Sakai S; Murayama T; Koshimura S; Saito M
    J Surg Oncol; 1990 Oct; 45(2):103-9. PubMed ID: 2214788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conservative treatment of bronchogenic carcinoma.
    Rohwedder JJ
    Compr Ther; 1979 Oct; 5(10):66-73. PubMed ID: 227641
    [No Abstract]   [Full Text] [Related]  

  • 10. The relationship between immune reactivity, serum cortisol, and stage of disease in patients with non-oat-cell bronchogenic carcinoma.
    DeMeester TR; Golomb HM; Dudek P; Hunter RL; Fang VS
    Surgery; 1979 Jul; 86(1):130-7. PubMed ID: 572099
    [No Abstract]   [Full Text] [Related]  

  • 11. Alternative approaches to radiotherapy alone and radiotherapy as a part of a combined therapeutic approach for lung cancer.
    Holsti LR
    Cancer Chemother Rep 3; 1973 Mar; 4(2):165-9. PubMed ID: 4125739
    [No Abstract]   [Full Text] [Related]  

  • 12. Adjuvant immunotherapy for bronchogenic carcinoma: preliminary results.
    Takita H; Brugarolas A
    Cancer Chemother Rep 3; 1973 Mar; 4(2):293-8. PubMed ID: 4729333
    [No Abstract]   [Full Text] [Related]  

  • 13. Tumor doubling time and survival of men with bronchogenic carcinoma.
    Weiss W
    Chest; 1974 Jan; 65(1):3-8. PubMed ID: 4358467
    [No Abstract]   [Full Text] [Related]  

  • 14. Cytoxan therapy in the treatment of carcinoma of the lung. (Report of a five-year survival).
    Castro L
    W V Med J; 1974 Jun; 70(6):131-5. PubMed ID: 4524737
    [No Abstract]   [Full Text] [Related]  

  • 15. [Multitest evaluation of the immune status of patients with bronchogenic carcinoma before and after radiotherapy].
    Gava A; Fontan L; Marazzato G; De Angeli S
    Minerva Med; 1990 Mar; 81(3):135-8. PubMed ID: 2320281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation plus 5-fluorouracil (NSC-19893): clinical demonstration of an additive effect in bronchogenic carcinoma.
    Cohen JL; Krant MJ; Shnider BI; Matias PI; Horton J; Baxter D
    Cancer Chemother Rep; 1971 Jun; 55(3):253-8. PubMed ID: 5115846
    [No Abstract]   [Full Text] [Related]  

  • 17. [Does prophylactic whole-brain irradiation in small-cell bronchial carcinoma at the "limited disease" stage improve overall survival?].
    Rübe C
    Strahlenther Onkol; 1996 Mar; 172(3):176-7. PubMed ID: 8721269
    [No Abstract]   [Full Text] [Related]  

  • 18. Preoperative x-ray therapy as an adjuvant in the treatment of bronchogenic carcinoma.
    Shields TW; Higgins GA; Lawton R; Heilbrunn A; Keehn RJ
    J Thorac Cardiovasc Surg; 1970 Jan; 59(1):49-61. PubMed ID: 5410189
    [No Abstract]   [Full Text] [Related]  

  • 19. Primary bronchogenic carcinoma in transplant recipients.
    Delcambre F; Pruvot FR; Ramon P; Noël C; Pol A; Jaillard-Théry S; Dupont J; Declerck N; Gosselin B; Rémy-Jardin M; Wurtz A; Laffite JJ
    Transplant Proc; 1996 Oct; 28(5):2884-5. PubMed ID: 8908109
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of the TNM system for the comparison of results of x-ray and cobalt teletherapy in unoperable bronchial carcinoma].
    Franke HD; Haug HP; Stephan G
    Strahlentherapie; 1967 Feb; 132(2):161-72 contd. PubMed ID: 4175222
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.